US Pharma MarketingThe post Dexcom’s G7 CGM helps TD2 diabetics not on insulin manage glucose levels appeared first on Medical Device Network.
Dexcom’s G7 CGM helps TD2 diabetics not on insulin manage glucose levels
Dexcom anticipates that the findings could drive a shift in the standard of care for type 2 diabetes patients who do not use insulin. Dexcom anticipates that the findings could drive a shift in the standard of care for type 2 diabetes patients who do not use insulin. The study’s findings were presented at the 2026 American Diabetes Association’s (ADA) Scientific Sessions, held between 5-8 June in New Orleans, Louisiana. Credit: JHVEPhoto / Shutterstock.com New data from Dexcom has demonstrated the benefit of its G7 continuous glucose monitor (CGM) in type 2 diabetes (TD2) patients not receiving insulin, suggesting a…
Dexcom anticipates that the findings could drive a shift in the standard of care for type 2 diabetes patients who do not use insulin.
Source: Medical Device Network